Remote health monitoring for dogs: what the market is already asking for

Your customers don't lie awake worrying about where their dog is. They lie awake wondering whether it's okay.

That difference is the backbone for the commercial logic of remote health monitoring for dogs - and it is why this category is growing faster than GPS tracking did at the same stage of its adoption curve.

Location data solved one problem. It told owners where their dog went. Health monitoring is trying to answer something harder: is my dog okay right now, in ways I cannot see from across the room or across the city?

The demand signal is hard to argue with

The world's largest pet industry trade show just wrapped its most significant edition to date. Interzoo 2026, held in Nuremberg in May, drew 39,000 trade visitors from over 130 countries and 2,400 exhibitors - the largest in the fair's history.

The headline figures matter less than one specific structural change: for the first time in Interzoo's history, the show launched a dedicated Product Showcase Healthcare area, with strict entry criteria requiring every product to meet verified health and safety standards to qualify. A dedicated Academy Session on healthcare ran alongside it. Buyers came to Nuremberg specifically for that floor.

Trade shows do not build verification systems for categories they are guessing at. They build them when buyer intent is already confirmed and the demand is organized enough to warrant its own infrastructure.

The numbers behind that decision come from Euromonitor International, presented by the firm's global pet care manager Sahiba Puri at Petfood Forum 2026 in Nuremberg: pet healthcare grew at a 12% compound annual growth rate between 2015 and 2025. The overall pet market grew 3.1% last year. Those are not two speeds of the same category. They are two different buyer priorities behaving differently for a decade.

The global pet care market reached approximately $207 billion in 2025, according to Euromonitor. Pet health and prevention is the fastest-growing segment inside that number, and it has been for ten years.

Within the wearables slice specifically, Grand View Research estimated the global pet wearable market at $2.7 billion in 2023 and projects it to reach $6.9 billion by 2030 at a 14.3% CAGR, with the health monitor sub-segment leading that expansion. Fortune Business Insights placed the market at $4.16 billion in 2025, reflecting faster-than-projected adoption.

Behind all of this is a structural shift in how pet owners relate to health. The American Pet Products Association reports that 66% of U.S. households own a pet - 86.9 million homes. A growing share of those owners treat pet health the way they treat their own: as something to monitor continuously, not check annually.

What separates health monitoring from activity tracking

This is where a lot of products in the category are still overselling their position.

Activity tracking counts steps, logs rest time, and estimates calories. It uses an accelerometer. It tells you how much your dog moved. It does not tell you whether the cardiovascular system is functioning normally.

Clinical-grade remote health monitoring captures different data: heart rate, respiratory rate, and in more advanced devices, BCG (ballistocardiography) - a measure of the mechanical forces generated by each heartbeat, used in human cardiology. Combined with HRV (heart rate variability), BCG data can surface anomalies that activity logs would miss entirely. A dog developing an early arrhythmia may complete its normal walks for days or weeks. The physiological signal appears before the behavioral one does.

That gap between "movement data" and "health data" determines everything downstream: which sensors go into the device, what the app can legitimately communicate to the user, and what claims your product can honestly make. Founders building in this space need that distinction clear in their product brief before a single unit goes into production.

PuresPet PHH-23 vs. Satellai Collar Go

Both products sit in the smart collar category. They are not built for the same purpose.

The Satellai Collar Go launched in late 2025 across Europe and the UK, priced at €79.99. Its positioning is built around GPS strength: 5 GNSS systems, coverage across 115 networks in 51 countries, a marketed battery life of up to 15 days, and an IP68 waterproof rating. The AI health layer, operating under the PetSense brand, is described in SATELLAI's own press materials as "real-time activity monitoring and intelligent alerts." That framing is accurate. The Collar Go is primarily a tracking and activity product with an alert layer added on top. It is well-executed for what it is.

The PuresPet PHH-23 is built around a different sensor architecture - and a different commercial premise.

Its core metrics are heart rate, respiratory rate, body movement, and BCG curve, captured continuously around the clock. The device generates HRV reports, sleep analysis, and health summaries, and flags abnormal readings for owner review. It connects over 4G Cat.1 with GPS and Wi-Fi positioning, includes electronic fence alerts and trajectory logging, and supports remote voice communication with one-key callback. CE and FCC certified, it is offered as an OEM/ODM product with a minimum order of 100 units per color and a customized production lead time of 25 to 30 days.

The honest trade-off: the PHH-23 has a 3-day battery life against the Collar Go's 15. BCG and respiratory monitoring draw significantly more power than a GPS radio and an accelerometer. That is a real hardware constraint, not a design oversight. It reflects the cost of actually measuring what it claims to measure.

If you are building a tracking product - one that answers "where is my dog" - the Collar Go represents a strong consumer benchmark. If you are building a health monitoring product - one that can show a dog owner their pet's HRV shifted three days before it stopped eating - the PHH-23 is operating in a different clinical register. The two products are not in direct competition. They are answers to different questions.

For a pet brand sourcing a white-label health device, that clinical register is what justifies the category premium. Pet owners who have already owned a GPS collar are not buying the same thing again. They are buying the next layer.

What this means for your product decisions now

The pet owners entering the market over the next five years are not early adopters. They have already owned a tracker. They know what activity data looks like. A significant share of them will pay more for a device that monitors cardiovascular health and flags a real anomaly - not one that congratulates their dog on hitting 10,000 steps.

Euromonitor's 12% healthcare CAGR over the last decade is not a projection. It is ten years of actual buyer behavior, now confirmed by an Interzoo that gave the category its own verified showcase floor for the first time. The window for building the right product in this category is narrowing as the category matures.

A wearable that tracks walks is becoming a commodity. A wearable that captures BCG data and surfaces a cardiac signal that an owner's eyes could never catch is still a product category with real differentiation.

The question is not whether demand will materialize. It already has. The question is what your product will actually be measuring when a customer's dog needs it most.

Frequently Asked Questions

What is remote health monitoring for dogs?

Remote health monitoring for dogs tracks physiological data in real time by using wearable sensors. These sensors usually go into the collar and transit data to a smartphone or application. There are basic and premium devices.

Basic devices track only activity data and rest time. Premium and advanced options monitor heart rate, respiratory rate, HRV, and BCG curve data.

How is remote health monitoring different from a GPS dog collar?

They answer two completely different questions. GPS collar tracks your dog, where he is, is he moving, is he running. Health monitoring devices answer the question how is your dog. Is his vital signs good? How is he sleeping, how is he moving.

Sometimes, the technologies can appear in the same device, but they use different sensors.

Can a remote health monitor detect illness in dogs before symptoms appear?

Yes, vets can use the data from a dog’s health monitor to make diagnosis even before the symptoms appear. We have seen this in human medicine. HRV changes and shifts in respiratory patterns can show something even before behavioral symptoms appear. A dog with a developing cardiac irregularity may maintain normal activity levels for days or weeks. But the biosensor can flag the anomaly before the dog starts acting unusual. There is still research to be done on clinical validation and BCG monitoring. But the technology is moving at a rapid pace.

Do vets recommend remote monitoring devices for dogs?

Adoption is growing in veterinary practice, particularly for post-surgical recovery and management of chronic conditions including heart disease and arthritis. Remote monitoring prevents frequent vet visits, especially during recovery time. Vets get a real-time view of the dog’s condition between the appointments.

What should a pet brand look for when sourcing a dog health monitor to white-label?

There are three things that are non-negotiable. The first one is sensor quality. Ask manufacturers questions like does the device capture actual physiological vitals - heart rate, respiratory rate, BCG, HRV - or only motion? The second question is certification, specifically CE and FCC compliance. These are a must for market entry in Europe and North America. Third, manufacturing flexibility. Talk about minimum order quantity, lead time, and more. These questions help you understand whether the manufacturer can support a real product roadmap.